119 related articles for article (PubMed ID: 2413056)
1. Inhibition of epidermal growth factor-induced phosphorylation by trifluoperazine.
Ross AH; Damsky C; Phillips PD; Hwang F; Vance P
J Cell Physiol; 1985 Sep; 124(3):499-506. PubMed ID: 2413056
[TBL] [Abstract][Full Text] [Related]
2. Comparison of protein phosphorylations in variant A431 cells with different growth responses to epidermal growth factor.
Buss JE; Chouvet C; Gill GN
J Cell Physiol; 1984 Jun; 119(3):296-306. PubMed ID: 6202705
[TBL] [Abstract][Full Text] [Related]
3. Effects of epidermal growth factor on transferrin receptor phosphorylation and surface expression in malignant epithelial cells.
Castagnola J; MacLeod C; Sunada H; Mendelsohn J; Taetle R
J Cell Physiol; 1987 Sep; 132(3):492-500. PubMed ID: 3498729
[TBL] [Abstract][Full Text] [Related]
4. Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors.
Sato JD; Kawamoto T; Le AD; Mendelsohn J; Polikoff J; Sato GH
Mol Biol Med; 1983 Dec; 1(5):511-29. PubMed ID: 6094961
[TBL] [Abstract][Full Text] [Related]
5. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
Fan Z; Masui H; Altas I; Mendelsohn J
Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
[TBL] [Abstract][Full Text] [Related]
6. Augmented desensitization to epidermal growth factor (EGF) immediate actions: a novel mechanism for altered EGF growth response in mutant A431 cells.
Karasik A; Reddy SS; Pepinsky RB; Brock T; Kahn CR
J Cell Physiol; 1990 Feb; 142(2):231-5. PubMed ID: 1689316
[TBL] [Abstract][Full Text] [Related]
7. Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies.
Masui H; Kawamoto T; Sato JD; Wolf B; Sato G; Mendelsohn J
Cancer Res; 1984 Mar; 44(3):1002-7. PubMed ID: 6318979
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of alpha-interferon on epidermal growth factor-mediated receptor-dependent events.
Fish EN; Ghislain J; Trogadis J; Stevens JK
Cancer Res; 1993 Nov; 53(21):5148-57. PubMed ID: 7693332
[TBL] [Abstract][Full Text] [Related]
9. Regulation by ceramide of epidermal growth factor signal transduction and mitogenesis in cell lines overexpressing the growth factor receptor.
Gallardo G; Tabraue C; Quintana J; López-Blanco F; Cabrera J; Díaz R; Estévez F; Ruiz de Galarreta CM; Fanjul LF; Santana P
Cell Mol Biol (Noisy-le-grand); 2000 Nov; 46(7):1305-12. PubMed ID: 11075960
[TBL] [Abstract][Full Text] [Related]
10. Effect of 12-O-tetradecanoylphorbol-13-acetate (TPA) on the growth inhibitory and increased phosphatidylinositol (PI) responses induced by epidermal growth factor (EGF) in A431 cells.
Smith KB; Losonczy I; Sahai A; Pannerselvam M; Fehnel P; Salomon DS
J Cell Physiol; 1983 Oct; 117(1):91-100. PubMed ID: 6311852
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor-receptor-protein kinase interactions.
Cohen S; Carpenter G; King L
Prog Clin Biol Res; 1981; 66 Pt A():557-67. PubMed ID: 6273929
[TBL] [Abstract][Full Text] [Related]
12. Loss of alpha 2-macroglobulin and epidermal growth factor surface binding induced by phenothiazines and naphthalene sulfonamides.
DiPaola M; Keith CH; Feldman D; Tycko B; Maxfield FR
J Cell Physiol; 1984 Feb; 118(2):193-202. PubMed ID: 6319437
[TBL] [Abstract][Full Text] [Related]
13. Early events in the antiproliferative action of tumor necrosis factor are similar to the early events in epidermal growth factor growth stimulation.
Donato NJ; Ince C; Rosenblum MG; Gallick GE
J Cell Biochem; 1989 Nov; 41(3):139-57. PubMed ID: 2482293
[TBL] [Abstract][Full Text] [Related]
14. Analysis of morphology and receptor metabolism in clonal variant A431 cells with differing growth responses to epidermal growth factor.
Lifshitz A; Lazar CS; Buss JE; Gill GN
J Cell Physiol; 1983 Jun; 115(3):235-42. PubMed ID: 6304117
[TBL] [Abstract][Full Text] [Related]
15. Loss of cytotoxic effect of epidermal growth factor (EGF) on EGF receptor overexpressing cells is associated with attenuation of EGF receptor tyrosine kinase activity.
Gardner DP; Shimizu N
J Cell Physiol; 1994 Feb; 158(2):245-55. PubMed ID: 8106561
[TBL] [Abstract][Full Text] [Related]
16. The protein kinase C inhibitor Go6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] potentiates agonist-induced mitogen-activated protein kinase activation through tyrosine phosphorylation of the epidermal growth factor receptor.
Shah BH; Olivares-Reyes JA; Catt KJ
Mol Pharmacol; 2005 Jan; 67(1):184-94. PubMed ID: 15465928
[TBL] [Abstract][Full Text] [Related]
17. Differential inhibitory effects of TGF-beta on EGF-, PDGF-, and HBGF-1-stimulated MG63 human osteosarcoma cell growth: possible involvement of growth factor interactions at the receptor and postreceptor levels.
Mioh H; Chen JK
J Cell Physiol; 1989 Jun; 139(3):509-16. PubMed ID: 2472412
[TBL] [Abstract][Full Text] [Related]
18. Anti-epidermal growth factor receptor monoclonal antibodies affecting signal transduction.
Reins HA; Steinhilber G; Freiberg B; Anderer FA
J Cell Biochem; 1993 Feb; 51(2):236-48. PubMed ID: 8382707
[TBL] [Abstract][Full Text] [Related]
19. Protamine inhibits platelet derived growth factor receptor activity but not epidermal growth factor activity.
Huang JS; Nishimura J; Huang SS; Deuel TF
J Cell Biochem; 1984; 26(4):205-20. PubMed ID: 6099364
[TBL] [Abstract][Full Text] [Related]
20. EGF induces cell cycle arrest of A431 human epidermoid carcinoma cells.
MacLeod CL; Luk A; Castagnola J; Cronin M; Mendelsohn J
J Cell Physiol; 1986 Apr; 127(1):175-82. PubMed ID: 3007537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
